{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:21:37Z","timestamp":1775179297211,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ygyno.2018.10.037","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T03:05:20Z","timestamp":1543460720000},"page":"316-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions"],"prefix":"10.1016","volume":"152","author":[{"given":"Monica Hagan","family":"Vetter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor J.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Bixel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-0966","authenticated-orcid":false,"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.10.037_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7150\/jca.2.153","article-title":"Retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies","volume":"2","author":"Demoor","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2018.10.037_bb0010","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ijgc-00009577-200501000-00003","article-title":"Carboplatin hypersensitivity","volume":"15","author":"Sliesoraitis","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.10.037_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-010-1338-5","article-title":"Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancer","volume":"67","author":"Sugimoto","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.10.037_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2011.04.019","article-title":"Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial","volume":"122","author":"Joly","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0030","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/bjc.2013.389","article-title":"Deleterious BRCA \u00bd mutation is an independent risk factor for carboplatin hypersensitivity reactions","volume":"109","author":"Moon","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2018.10.037_bb0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0040","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.ygyno.2018.10.037_bb0045","first-page":"261","article-title":"Acute infusion reactions to chemotherapeutic drugs: a single institute experience","volume":"18","author":"Muallaoglu","year":"2013","journal-title":"J. BUON"},{"key":"10.1016\/j.ygyno.2018.10.037_bb0050","author":"National Comprehensive Cancer Network"},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.037_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2009.10.070","article-title":"The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment","volume":"116","author":"O'Cearbhaill","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0091-6749(92)90142-O","article-title":"Anaphylaxis to carboplatin-a new platinum chemotherapeutic agent","volume":"90","author":"Windom","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2016.09.027","article-title":"Platinum desensitization in patients with carboplatin hypersensitivity: a single-institution retrospective study","volume":"144","author":"Altwerger","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.10.037_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2014.07.104","article-title":"Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin\/cisplatin","volume":"135","author":"Li","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ygyno.2017.03.015","article-title":"Outpatient desensitization in selected patients with platinum hypersensitivity reactions","volume":"145","author":"O'Malley","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.10.037_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10147-014-0731-1","article-title":"4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study","volume":"20","author":"Takase","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0090-8258(03)00066-0","article-title":"Carboplatin hypersensitivity reactions: re-treatment with cisplatin desensitization","volume":"89","author":"Jones","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cncr.21168","article-title":"Successful carboplatin desensitization in patients with proven carboplatin allergy","volume":"104","author":"Confino-Cohen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.10.037_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2018.10.037_bb0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818313520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T10:41:02Z","timestamp":1571222462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818313520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0090825818313520"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.037","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}